Marie Odile Petillon

Statistics

Publications

Citations

391

H-Index

Active since

2010

Affiliations

Hôpital Claude Huriez(Current)

Centre Hospitalier Universitaire de Tours

Hôpital Purpan

Sorbonne Université

Hôpital Saint-Antoine

Marie Odile Petillon is an author at Hôpital Claude Huriez specializing in hematologic malignancy pharmacotherapy, hematologic oncology, and chemotherapy.

Publications per year

2010–2016

Publications

Pomalidomide plus low-dose dexamethasone is active and well tolerated in bortezomib and lenalidomide–refractory multiple myeloma: Intergroupe Francophone du Myélome 2009-02

Xavier Leleu, Michel Attal, Bertrand Arnulf et al. · Blood · 2013 · 208 citations

Medicine, Hematology, Pharmacotherapy +16

Pomalidomide plus low-dose dexamethasone in multiple myeloma with deletion 17p and/or translocation (4;14): IFM 2010-02 trial results

Xavier Leleu, Lionel Karlin, Margaret Macro et al. · Blood · 2015 · 101 citations

Medicine, Hematology, Oncology +14

IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myeloma

Eileen M. Boyle, Guillemette Fouquet, Stéphanie Guidez et al. · Cancer · 2014 · 36 citations

Life Sciences, Immunology, Pathology +17

High Response Rates to Pomalidomide and Dexamethasone in Patients with Refractory Myeloma, Final Analysis of IFM 2009-02

Xavier Leleu, Michel Attal, Bertrand Arnulf et al. · Blood · 2011 · 21 citations

Medicine, Hematology, Pharmacotherapy +10

Phase 2 Study of 2 Modalities of Pomalidomide (CC4047) Plus Low-Dose Dexamethasone as Therapy for Relapsed Multiple Myeloma. IFM 2009-02

Xavier Leleu, Michel Attal, Philippe Moreau et al. · Blood · 2010 · 14 citations

Medicine, Hematology, Pharmacotherapy +15

1–5 of 6